Cannabis-based medicine in spasticity caused by multiple sclerosis
Sativex in patients suffering from multiple sclerosis associated detrusor overactivity
The effect of cannabis on urge incontinence in patients with multiple sclerosis
Nabilone significantly reduces spasticity-related pain
Cannabinoids in multiple sclerosis (CAMS) study
Sativex produced significant improvements in a subjective measure of spasticity
Cannabis-based medicine in central pain in multiple sclerosis.
Do cannabis-based medicinal extracts have general or specific effects
Efficacy, safety and tolerability of an oral cannabis extract in the treatment of spasticity
cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.
Are oral cannabinoids safe and effective in refractory neuropathic pain?
Dronabinol in the treatment of agitation in patients with Alzheimer’s disease with anorexia
Cannabis based medicinal extracts (CBME) in central neuropathic pain due to multiple sclerosis.
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis
Cannabis based medicinal extract on refractory lower urinary tract dysfunction
Analgesic effect of the cannabinoid analogue nabilone
The perceived effects of smoked cannabis on patients with multiple sclerosis.
Orally and rectally administered delta-9-tetrahydrocannabinol on spasticity
Nabilone in the treatment of multiple sclerosis
Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
Tetrahydrocannabinol for tremor in multiple sclerosis.
Marihuana as a therapeutic agent for muscle spasm or spasticity
Cannabis-based medicine in spasticity caused by multiple sclerosis.
Cannabis based treatments for neuropathic and multiple sclerosis-related pain.
The effect of cannabis on urge incontinence in patients with multiple sclerosis
Cannabis' Potential Exciting Researchers in Treatment of ALS, Parkinson's Disease
The endocannabinoid system is dysregulated in multiple sclerosis
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Nabilone The synthetic cannabinoid nabilone improves pain and symptom management in cancer patients
Nabilone versus prochlorperazine
Dronabinol for supportive therapy in patients with malignant melanoma and liver metastases.
Nausea relieved by tetrahydrocannabinol (dronabinol).
An efficient new cannabinoid antiemetic in pediatric oncology.
Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.
Marijuana as antiemetic medicine
Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy
Inhalation marijuana as an antiemetic for cancer chemotherapy.
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children
Acute and subacute bronchial effects of oral cannabinoids.
Nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
Dose vs response of tetrahydroannabinol (THC) vs prochlorperazinedelta 9-
Comparative trial of the antiemetic effects of THC and haloperidol
Comparison of delta-9- tetrahydrocannabinol and prochlorperazine.
Tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications.
Antiemetic effect of tetrahydrocannabinol
The antiemetic activity of tetrahydrocanabinol versus metoclopramide and thiethylperazine
The antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
Delta-9- tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9- THC.
Superiority of nabilone over prochlorperazine as an antiemetic
Antiemetic effect of delta-9- tetrahydrocannabinol in patients receiving cancer chemotherapy.
Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids
The Endocannabinoid-CB Receptor System
Ganja use among Jamaican women.
Dreher's Jamaican Pregnancy Study
Nonmutagenic action of cannabinoids in vitro
Prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth.
Tobacco and marijuana use on offspring growth from birth through 3 years of age.
Prenatal marijuana use and neonatal outcome.
Topical cannabinoid agonists : An effective new possibility for treating chronic pruritus.
Dronabinol in patients with intractable pruritus secondary to cholestatic liver disease.
Cannabidiol as an antipsychotic
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients
Delta-9- Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition
Cannabis does not induce schizophrenia,
Cannabis use does not cause schizophrenia
Cannabis as a psychotropic medication
Study Shows Long Term Marijuana Users Healthy
Cannabis and schizophrenia link blurs further
Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension
Cannabis-based medicine in central pain in multiple sclerosis.
Two cannabis based medicinal extracts for relief of central neuropathic pain
Functional role for cannabinoids in respiratory stability during sleep
THC reduces sleep apnoea in animal research
Cannabis-based medicine in spasticity caused by multiple sclerosis
Cannabinoids in multiple sclerosis
Sativex produced significant improvements in a subjective measure of spasticity
Do cannabis-based medicinal extracts have general or specific effects on symptoms in ms?
Efficacy, safety and tolerability of an oral cannabis extract in the treatment of spasticity
Are oral cannabinoids safe and effective in refractory neuropathic pain?
Experiences with THC-treatment in children and adolescents
The treatment of spasticity with D9-THC in patients with spinal cord injury
The effect of orally and rectally administered delta-9- tetrahydrocannabinol on spasticity
Nabilone in the treatment of multiple sclerosis.
Treatment of spasticity in spinal cord injury with dronabinol
Delta-9- tetrahydrocannabinol shows antispastic and analgesic effects
Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.
Delta-9- THC in the treatment of spasticity associated with multiple sclerosis.
Delta(9)-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
9-Tetrahydrocannabinol Inhibits Cell Cycle Progression in Human Breast Cancer
THC and prochlorperazine effective in reducing vomiting in women following breast surgery
{Delta}9-Tetrahydrocannabinol- Induced Apoptosis in Jurkat Leukemia T Cells
Delta(9)-THC) prevents cerebral infarction
Medical marijuana: study shows that THC slows atherosclerosis
Delta-9- tetrahydrocannabinol shows antispastic and analgesic effects
The effect of delta-9- THC on human spasticity.
The treatment of spasticity with D9-THC) in patients with spinal cord injury
Delta-9- THC as an alternative therapy for overactive bladders in spinal cord injury
The effect of orally and rectally administered delta-9- tetrahydrocannabinol on spasticity
The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury.
Delta-9- Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition